Across TCGA pan-cancer cohorts, CTAGE4 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CTAGE4 data layer compared with 17 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CTAGE4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CTAGE4 expression acts as an unfavorable survival marker.

UCEC and SKCM are the cancer types where CTAGE4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
SKCM	DFS	Median	All	0.192	0.757	.022	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: CTAGE4 tumor-vs-normal RNA expression · all CTAGE4 data types